DPDoctor's PassportEducation
Dermatology indexPassport
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Textbook/Dermatology/Photography, body maps and lesion monitoring
Full textbookMLAMSRAGP

Photography, body maps and lesion monitoring

Create consented, standardised and securely governed skin images and body maps that support comparison, referral and surveillance without delaying biopsy of suspicious change.

22 min full readUK scopeSources checked 27 Aug 2026Clinical review pending
!
Time-critical presentation

Escalate urgently when assessment for Photography, body maps and lesion monitoring reveals systemic toxicity, airway or eye involvement, extensive skin failure, a non-blanching eruption in an unwell patient, or a rapidly changing lesion suspicious for aggressive malignancy.

Open the sections you need. The overview is shown first.
01Purpose and principlesWhat the assessment is for and the core concepts behind it.

Clinical images can document extent, transmit morphology for advice and reveal change that memory misses. Standardisation matters: reproduce camera distance, angle, lighting, patient position and measurement. Include enough surrounding anatomy for localisation while excluding unnecessary identifiers and intimate exposure.

Consent is a continuing conversation. Explain why the image is needed, where it will be stored, who may view it, whether it could be used beyond direct care and how withdrawal works. For intimate areas, use a chaperone and minimise capture. Respect refusal without compromising explanation of alternative documentation.

Photography, body maps and lesion monitoring should answer a defined clinical question and be integrated with history, examination and the consequences of error. Explain uncertainty, record the sampling or observation conditions, and arrange a result-review plan rather than treating an isolated finding as self-interpreting.

Key points

  • Obtain and document consent for image capture, storage and each proposed secondary use; clinical-care consent does not automatically authorise teaching or publication.
  • Use an overview image to locate the site, a regional view for distribution and a close-up with scale, focus and neutral colour reference when appropriate.
  • Body maps must specify side, landmark, lesion number and date so a later clinician can find the same lesion.
  • Store images only in the approved clinical record or secure system; personal phones, consumer cloud backups and informal messaging create confidentiality risk.
  • For Photography, body maps and lesion monitoring, describe what is seen before assigning a diagnosis, and record site, extent, symptoms, duration and change over time.
  • A technically adequate result in Photography, body maps and lesion monitoring can still be misleading when the wrong lesion, site, preparation or clinical question was selected.
02Indications, selection and cautionsWhen it is useful, when urgency changes and important limitations.
Reliable lesion identity

A site label, body-map coordinate and regional locator image prevent comparison with a neighbouring mole by mistake.

Measurable evolution

Change in diameter, elevation, colour, ulceration or symptoms is interpretable only when scale and technique are sufficiently consistent.

Image quality failure

Blur, glare, shadow, colour shift or absent anatomical context can create false change and should trigger repeat capture.

Safeguarding and dignityRed flag

Images involving children, intimate skin or coercive circumstances need particularly careful consent, chaperoning and access control.

Cancer warning changeRed flag

New nodularity, rapid enlargement, spontaneous bleeding or ulceration requires clinical reassessment rather than another routine photograph.

Red flags requiring action

  • Do not substitute serial photography for urgent referral or tissue diagnosis when a lesion is rapidly changing, nodular, ulcerated, bleeding or otherwise clinically suspicious.
03Method and interpretationA systematic approach to the test and its findings.
Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

  1. 01
    Overview, regional and close-up image setFirst step
    Why
    Record distribution, location and morphology at complementary scales.
    Interpretation and limitations
    Check focus and exposure before the patient leaves; an isolated macro image may be impossible to relocate.
  2. 02
    Millimetre scale and orientation marker
    Why
    Support reproducible lesion measurement and side identification.
    Interpretation and limitations
    Place the scale in the same plane without obscuring the edge; perspective distortion invalidates direct size comparison.
  3. 03
    Body map with unique lesion identifier
    Why
    Link each image to precise anatomy and longitudinal records.
    Interpretation and limitations
    Use stable landmarks and laterality, and reconcile removed or newly numbered lesions at every review.
  4. 04
    Secure metadata and audit trail
    Why
    Preserve date, authorship, consent scope and clinical purpose.
    Interpretation and limitations
    Metadata can itself identify a patient; approved storage and role-based access remain necessary after visible identifiers are cropped.
04Clinical next stepsHow the result changes management or prompts escalation.
01Planned assessmentUse serial clinical imaging systematicallyFirst stepThe patient is stable and the result will alter diagnosis, referral or follow-up.
  1. 1Define the question for Photography, body maps and lesion monitoring, explain the process and obtain valid consent before exposing, touching, photographing or sampling skin.
  2. 2Choose representative anatomy, optimise lighting or specimen technique, and document site, morphology, symptoms and relevant previous treatment. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
  3. 3Interpret the result beside the full clinical pattern, communicate uncertainty and arrange ownership of results and safety-netting. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
02Uncertain resultResolve discordance in Photography, body maps and lesion monitoringThe technical finding conflicts with the history, lesion evolution or wider examination.
  1. 1Recheck identity, site, timing, preparation, treatment exposure and whether the selected target was genuinely representative. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
  2. 2Repeat or select a complementary test only when it can distinguish the remaining important alternatives. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
  3. 3Seek dermatology, pathology, microbiology or allergy advice when clinicopathological disagreement would change urgent care. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
03Urgent patternDo not let serial clinical imaging delay escalationEscalationA rapidly progressive eruption, systemic illness, threatened vision or airway, or suspected aggressive malignancy is present. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
  1. 1Stabilise immediate physiological threats and obtain same-day senior or specialty assessment according to the dominant emergency. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
  2. 2DefinitiveTake time-critical images or specimens only when doing so will not postpone resuscitation, antimicrobials or definitive referral. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
  3. 3Record evolution and communicate the differential, outstanding results and explicit deterioration triggers during handover. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
05Risks, monitoring and follow-upComplications, safety checks and further assessment.
  • Record who will review the result arising from Photography, body maps and lesion monitoring, the expected timescale and the action threshold before the patient leaves.
  • Compare subsequent findings with the original site description, dimensions, symptoms and image or specimen identifiers for Photography, body maps and lesion monitoring.
  • Reassess earlier if rapid growth, bleeding, ulceration, fever, mucosal disease, eye symptoms or functional compromise develops. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
  • Document technical limitations and previous treatment that could alter sensitivity or specificity of serial clinical imaging.
  • Close the loop after specialist or laboratory review, including clinicopathological disagreement and any need for repeat sampling. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
06Special situationsVariants, exceptions and circumstances that change the usual approach.

Three distances answer three questions

Overview locates distribution, regional framing identifies anatomy, and close-up records the lesion’s discriminating detail.

Scale belongs in plane

A ruler above curved skin or at a different distance produces misleading measurements despite appearing precise.

Colour needs consistency

Automatic white balance and room lighting can imitate erythema or pigment change between visits.

Consent is purpose-specific

Care, remote advice, education and publication are different uses and should not be bundled silently.

Recall systems prevent harm

Monitoring is safe only when the interval, responsible team and non-attendance process are explicit.

07Common pitfallsFrequent interpretation and management errors.
  1. 01

    Taking a close-up without a regional locator and later comparing the wrong lesion.

  2. 02

    Using a personal device whose gallery or cloud service stores an uncontrolled copy.

  3. 03

    Assuming absence of visible growth on mismatched photographs excludes important clinical change.

  4. 04

    Cropping an image after capture and overlooking identifying tattoos, jewellery or background information.

  5. 05

    Repeating images of a suspicious nodule instead of initiating the appropriate urgent assessment.

Practice

Two practice questions

Question 1 of 20 correct
DermatologyOriginal SBA

Safe lesion series

A clinician photographs a mole selected for specialist short-interval monitoring in secondary care. Which image set best supports reliable later review?

Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom